Resources

Photosensitive Epilepsy & COVID-19

January 25, 2021

Photosensitive epilepsy is a type of stimulus-induced reflex epilepsy that affects 3-5% of the 2.7 million Americans living with epilepsy. Various preventative strategies exist to avoid stimulus-induced seizures, especially in regards to COVID-19, and should be tailored to the specific needs of the individual at the recommendation of the treating physician.

Learn More

Learn about SYMPAZAN by Aquestive

August 7, 2020

For years, clobazam was only available in pills or liquids. Thanks to PharmFilm technology, SYMPAZAN is the only product to offer clobazam in a convenient film.

Learn More

FDA Approves FINTEPLA® (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome

July 1, 2020

FINTEPLA® significantly and substantially reduced convulsive seizure frequency in patients whose seizures were not adequately controlled on other medications, as observed in two phase 3 placebo-controlled clinical trials.

Learn More

Disability Rights Maine - Client Assistance Program

June 3, 2020

The Client Assistance Program (CAP) is a federally funded program that provides information, assistance, and advocacy to people with disabilities who are applying for or receiving services under the Rehabilitation Act.

Learn More